Jan S. Wolpert
President

Jan Wolpert is the founder and principal owner of Wolpert Associates, Inc. (“WAI”), a strategic transaction advisory firm for the life sciences community (www.wolpertassociatesinc.com).  Spanning a career of over 30 years, he has led the conceptualization and execution of hundreds of complex corporate development and new venture transactions and initiatives across all health care and life science sectors, as well as other rapidly changing industries.  Conducting business through WAI since 2010, he has advised a roster of international companies on strategic transaction initiatives cutting across a multiplicity of therapeutic areas – e.g., oncology, neuroscience, cardio-metabolic, infectious disease disorders – primarily involving biopharmaceutical therapeutics, and in select instances, medical devices, healthcare services and other life science sectors. WAI’s perspective is unique in focusing on the intersection between scientific innovation, characteristics of global and regional medical markets, overall corporate development, and value creation – all themes that are particularly sensitive to well-conceived strategic transaction initiatives. 

From 2004-2010, Mr. Wolpert was the Chief Executive Officer of Clearview Projects, Inc., a global strategic advisory firm dedicated to the biopharma sector.  Under his leadership at Clearview, he secured and oversaw strategic transaction engagements involving clients headquartered in the US, EU, Japan, India and China (such clients ranging from early-stage venture-backed companies to large Japan/India-HQ enterprises) across a diverse array of pipeline therapeutic areas and technologies. Prior to joining Clearview, Mr. Wolpert was Vice President - Corporate Development at Pharmacia (now an affiliate of Pfizer) and its predecessor Monsanto Company, where he directed the corporation’s complex restructuring and growth transaction activities beginning in the mid-1990s through to its merger with Pfizer in 2003.

Jan has extensive executive and strategic transaction experience in all of the major life science and health care markets around the world – including US, pan-EU, Japan, India and China. As a recognized expert on corporate transactions and strategic planning in the biopharmaceutical and life science sectors, Mr. Wolpert has authored numerous articles in well-respected business publications and has been a panelist or speaker at leading industry conferences around the world. He holds an M.B.A. degree from The Wharton School of the University of Pennsylvania and a B.S. in electrical engineering (honors) from The University of Maryland at College Park.  Jan is married and resides in New York City.

 

Wolpert Associates, Inc.